BJDX - CIK 0001704287
The table below shows Bluejay Diagnostics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | $249.04K | - | - |
| Cost of revenue | - | - | - | $200.13K | - | - |
| Gross profit | - | - | - | $48.91K | - | - |
| R&D | $3.05M | $3.47M | $5.71M | $4.15M | $1.15M | $527.25K |
| SG&A | $3.91M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.69M |
| $283.44K |
| $451.42K |
| $1.79M |
| $596.12K |
| Operating income | -$6.95M | -$7.17M | -$10.31M | -$9.32M | -$3.23M | -$1.20M |
| Income tax | - | - | - | - | - | - |
| Net income | -$6.85M | -$7.72M | -$9.95M | -$9.30M | -$3.49M | -$1.16M |
| EPS (diluted) | -$15.25 | -$456.75 | -$3.63K | -$9.22 | -$0.41 | - |